DAIICHI SANKYO COMPANY, LIMITED
Patent Owner
Stats
- 279 US PATENTS IN FORCE
- 35 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 279 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,502 Total Citation Count
- Jun 20, 1986 Earliest Filing
- 201 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0071,403 ANTIBODY-DRUG CONJUGATE PRODUCED BY BINDING THROUGH LINKER HAVING HYDROPHILIC STRUCTURENov 22, 17Mar 15, 18[C07K]
2018/0073,084 METHOD FOR PREDICTING RESPONSIVENESS TO PHOSPHATIDYLSERINE SYNTHASE 1 INHIBITORMar 15, 16Mar 15, 18[C12Q, C12N]
2017/0296,521 PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF THROMBOEMBOLISM AFTER STENT PLACEMENTSep 01, 15Oct 19, 17[A61K]
2017/0283,885 ALGORITHMS FOR GENE SIGNATURE-BASED PREDICTOR OF SENSITIVITY TO MDM2 INHIBITORSOct 09, 15Oct 05, 17[A61K, C12Q, G01N]
2017/0260,529 POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELINGMay 24, 17Sep 14, 17[A61K, C12Q, C12N, G01N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9918938 Selective production method for D-mannitol α-form crystal using spray-drying methodSep 29, 14Mar 20, 18[A61K, C07C]
9920071 Method for producing inhibitor of activated blood coagulation factor X (FXa)Feb 13, 15Mar 20, 18[A61K, C07D]
9872924 Antibody-drug conjugate produced by binding through linker having hydrophilic structureOct 17, 13Jan 23, 18[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0114,035 Method for Manufacturing Neuraminic Acid DerivativesAbandonedJan 09, 17Apr 27, 17[C07D]
2017/0080,049 MEDICINE AGAINST GROWTH FAILURE INDUCED BY ADMINISTRATION OF STEROIDAbandonedFeb 26, 15Mar 23, 17[A61K]
2017/0022,220 HIGH-PURITY CRYSTALS OF ACTIVE BLOOD COAGULATION FACTOR X (FXA) INHIBITORAbandonedFeb 23, 15Jan 26, 17[C07D, C07C]
2016/0206,593 PHARMACEUTICAL FOR PROPHYLAXIS OR TREATMENT OF HYPERTENSIONAbandonedJan 14, 16Jul 21, 16[A61K]
2016/0137,644 METHOD FOR PRODUCING TRICYCLIC HETEROCYCLIC COMPOUNDAbandonedJun 25, 14May 19, 16[C07D, B01D]
2016/0130,663 METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENTAbandonedJul 11, 14May 12, 16[C12Q, C12N, G01N]
2016/0128,972 METHOD FOR PREVENTING INFLUENZA VIRUS INFECTION BY ADMINISTERING A DRY POWDER PHARMACEUTICAL COMPOSITIONAbandonedDec 07, 15May 12, 16[A61K]
2016/0129,008 Solid Dosage Form of Olmesartan Medoxomil and AmlodipineAbandonedJun 09, 15May 12, 16[A61K]
2016/0102,079 ACETONE SOLVATE CRYSTALS OF TRITYL OMESARTAN MEDOXOMILAbandonedOct 14, 14Apr 14, 16[C07D]
2016/0052,906 METHOD FOR MANUFACTURING NEURAMINIC ACID DERIVATIVESAbandonedSep 09, 15Feb 25, 16[C07D]
2015/0353,577 METHOD FOR PRODUCING (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONEAbandonedMar 28, 14Dec 10, 15[C07D, C07C]
2015/0239,909 PROCESS FOR THE PREPARATION OF (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONEAbandonedMay 13, 15Aug 27, 15[C07D, C07C]
2015/0147,326 PROTEIN BIOMARKER AND USES THEREOFAbandonedSep 30, 14May 28, 15[A61K, G01N, A61N, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.